Administration of modified spherosome suspension (BY963) leads to an increase of acoustic impedance in dog brain tissue.
Ultrasound contrast agents change the acoustic properties of brain tissue. This can be quantified with acoustic densitometry. In a dog model, the authors examined changes in acoustic impedance in the thalamic and parietal white-matter regions of the brain after intravenous injection of the spherosome containing an ultrasound contrast agent (BY963) filled with perfluoropentane gas. The authors examined six sedated mongrel dogs with a Hewlett-Packard Sonos 1500 device. BY963 filled with perfluoropentane (0.2 ml/kg body weight) was injected three times with a time interval between injections of 5 minutes. Time-dependent changes in mean acoustic impedance were calculated. The authors found a significant increase in peak acoustic impedance after fractional injection of 0.6 ml/kg body weight (3 x 0.2 ml/kg body weight) in the thalamus region up to 7.0 IU (p = 0.006). In the parietal white matter the increase in peak acoustic impedance was not significant (p = 0.06). Statistical comparison of the increase in peak acoustic impedance between placebo and BY963 injection in the thalamus region showed a significant difference after the first injection (p = 0.01) but showed no significance after the second and third injections. The authors concluded that thalamus and parietal white matter of the brain showed different accumulations of BY963.
Seidel
G
G
Neurologische Universitätsklinik, Lübeck, Germany.
Beller
K D
KD
Kaps
M
M
D000818:Animals; D003287:Contrast Media; D004285:Dogs; D004453:Echoencephalography; D008297:Male; D010713:Phosphatidylcholines; D012680:Sensitivity and Specificity
C096494:BY 963; D003287:Contrast Media; D010713:Phosphatidylcholines